These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17900042)

  • 1. Chronic stress and insulin resistance-related indices of cardiovascular disease risk, part 2: a potential role for mind-body therapies.
    Innes KE; Vincent HK; Taylor AG
    Altern Ther Health Med; 2007; 13(5):44-51. PubMed ID: 17900042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic stress and insulin resistance-related indices of cardiovascular disease risk, part I: neurophysiological responses and pathological sequelae.
    Innes KE; Vincent HK; Taylor AG
    Altern Ther Health Med; 2007; 13(4):46-52. PubMed ID: 17658122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk indices associated with the insulin resistance syndrome, cardiovascular disease, and possible protection with yoga: a systematic review.
    Innes KE; Bourguignon C; Taylor AG
    J Am Board Fam Pract; 2005; 18(6):491-519. PubMed ID: 16322413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges associated with metabolic syndrome.
    Spinler SA
    Pharmacotherapy; 2006 Dec; 26(12 Pt 2):209S-217S. PubMed ID: 17125447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance (metabolic) syndrome in children.
    Rosenberg B; Moran A; Sinaiko AR
    Panminerva Med; 2005 Dec; 47(4):229-44. PubMed ID: 16489322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiometabolic risk reduction in an intensive cardiovascular health program.
    Voeghtly LM; Neatrour DM; Decewicz DJ; Burke A; Haberkorn MJ; Lechak F; Patney HL; Vernalis MN; Ellsworth DL
    Nutr Metab Cardiovasc Dis; 2013 Jul; 23(7):662-9. PubMed ID: 22633795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance.
    Kendall DM; Harmel AP
    Am J Manag Care; 2002 Dec; 8(20 Suppl):S635-53; quiz S654-7. PubMed ID: 12510788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of the literature examining the physiological processes underlying the therapeutic benefits of Hatha yoga.
    Dunn KD
    Adv Mind Body Med; 2008; 23(3):10-8. PubMed ID: 20664144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance and the metabolic syndrome as predictors of cardiovascular risk: where are we now?
    Sattar N
    Minerva Endocrinol; 2005 Sep; 30(3):121-38. PubMed ID: 16208304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolic syndrome in South Asians: epidemiology, determinants, and prevention.
    Misra A; Khurana L
    Metab Syndr Relat Disord; 2009 Dec; 7(6):497-514. PubMed ID: 19900153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yoga could be good for heart disease. Simultaneous focus on body, breathing, and mind may be just what the doctor ordered.
    Harv Heart Lett; 2010 Nov; 21(3):5. PubMed ID: 21162175
    [No Abstract]   [Full Text] [Related]  

  • 13. Mind-body fitness: encouraging prospects for primary and secondary prevention.
    La Forge R
    J Cardiovasc Nurs; 1997 Apr; 11(3):53-65. PubMed ID: 9095454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychological risk factors and cardiovascular disease: is it all in your head?
    Menezes AR; Lavie CJ; Milani RV; O'Keefe J; Lavie TJ
    Postgrad Med; 2011 Sep; 123(5):165-76. PubMed ID: 21904099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic evaluation of the insulin resistance syndrome as an independent risk factor for cardiovascular disease mortality and derivation of a clinical index.
    Godsland IF; Lecamwasam K; Johnston DG
    Metabolism; 2011 Oct; 60(10):1442-8. PubMed ID: 21459390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus.
    Rader DJ
    Am J Med; 2007 Mar; 120(3 Suppl 1):S12-8. PubMed ID: 17320517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of stress in the pathogenesis of the metabolic syndrome.
    Rosmond R
    Psychoneuroendocrinology; 2005 Jan; 30(1):1-10. PubMed ID: 15358437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menopause, the metabolic syndrome, and mind-body therapies.
    Innes KE; Selfe TK; Taylor AG
    Menopause; 2008; 15(5):1005-13. PubMed ID: 18779682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SLE and metabolic syndrome.
    Parker B; Bruce I
    Lupus; 2013 Oct; 22(12):1259-66. PubMed ID: 24097998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.